<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font6" size="8" family="GillSans" color="#000000"/>
<text top="41" left="55" width="48" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>CytoJournal</i></text>
<text top="41" left="103" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2006, </text>
<text top="41" left="131" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>3</b></text>
<text top="41" left="136" width="12" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:24</text>
<text top="41" left="387" width="167" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.cytojournal.com/content/3/1/24</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t6" reading_order_no="110" segment_no="9" tag_type="text">Page 6 of 8</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="111" segment_no="10" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="32" segment_no="5" tag_type="text">tion exists in the smears. A major disadvantage inherent in</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="33" segment_no="5" tag_type="text">the FNAC smear is the inability to identify a follicular</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="34" segment_no="5" tag_type="text">growth pattern <a href="">[15], which</a> is a major prognostic factor.</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="35" segment_no="5" tag_type="text">After the introduction of REAL and WHO classification,</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="36" segment_no="5" tag_type="text">the major emphasis has been given on cell morphology</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="37" segment_no="5" tag_type="text">and immunopheotype rather than the growth pattern</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="38" segment_no="5" tag_type="text"><a href="">[13,14]</a>. In the present paper, we attempted to apply the</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="39" segment_no="5" tag_type="text">combined approach of FNAC and FCI to implement</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="40" segment_no="5" tag_type="text">WHO classification on FNAC. FCI showed light chain</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="41" segment_no="5" tag_type="text">restriction in 75% (30/40) cases of B-NHL. In rest of the</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="42" segment_no="5" tag_type="text">ten cases, there were predominant CD19 and CD20 posi-</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="43" segment_no="5" tag_type="text">tive cell populations (&gt;80%). Considering the cytomor-</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="44" segment_no="5" tag_type="text">phology and predominant CD 19 and CD20 expression,</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="45" segment_no="5" tag_type="text">we considered these cases as B-NHL. The lack of expres-</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="46" segment_no="5" tag_type="text">sion of surface immunoglobulin light chains in B-NHL is</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="47" segment_no="5" tag_type="text">an unusual phenomenon. However, it has been also</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="48" segment_no="5" tag_type="text">noted by other au<a href="">thors [16,17]. Zardawi et al [17]</a></text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="49" segment_no="5" tag_type="text">encountered seven cases of B-NHL, which did not show</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="50" segment_no="5" tag_type="text">any light chain restriction on FCI. Similarly Zeepa et al</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="51" segment_no="5" tag_type="text"><a href="">[16] note</a>d 12 cases of B-NHL with no demonstrable light</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="52" segment_no="5" tag_type="text">chain restriction. In fact, it has been suggested by them</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="53" segment_no="5" tag_type="text">that CD20 positivity in excess of 85% is diagnostic of NHL</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="54" segment_no="5" tag_type="text">in a cytological suspicious case of lymphoma <a href="">[16].</a></text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="55" segment_no="8" tag_type="text">In addition to providing clear, quantitative evidence of</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="56" segment_no="8" tag_type="text">monclonality, FCI was helpful in subclassification of NHL</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="57" segment_no="8" tag_type="text">in 79% (38/48) cases. It was particularly helpful in sub-</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="58" segment_no="8" tag_type="text">classification of low grade B-NHL. The FNAC of small</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="59" segment_no="8" tag_type="text">lymphocytic lymphomas, mantle cell lymphomas and</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="60" segment_no="8" tag_type="text">low grade follicular lymphomas are difficult to differenti-</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="61" segment_no="8" tag_type="text">ate by cytomorphology alone. Combining CD 19 with</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="62" segment_no="8" tag_type="text">other antibodies such as CD 5, CD10, CD 23 and FMC 7</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="63" segment_no="8" tag_type="text">are usually helpful to distinguish these lesions. In the</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="64" segment_no="8" tag_type="text">present study, all the SLL cases, expressed both CD5 and</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="65" segment_no="8" tag_type="text">CD 23 antigen. SLL cases usually show absence of expres-</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="66" segment_no="8" tag_type="text">sion of CD 10 and FMC 7. Typically they show a low pro-</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="67" segment_no="8" tag_type="text">liferative index. In MCL, we noted only CD5 positive and</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="68" segment_no="8" tag_type="text">CD23 negative population of cells. We did not have FMC</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t45" reading_order_no="69" segment_no="8" tag_type="text">7 antibody in our laboratory for additional confirmation</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="70" segment_no="8" tag_type="text">in MCL cases. MCL is associated with characteristic</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="71" segment_no="6" tag_type="text">cytogenesis abnormality of t(11:14). This anomaly causes</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="72" segment_no="6" tag_type="text">overexpression of BCL1 gene, which encodes cycin D1. So</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="73" segment_no="6" tag_type="text">MCL are positive for cyclin D1 in addition to CD 5 posi-</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="74" segment_no="6" tag_type="text">tivity. This is an additional characteristic feature of MCL</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="75" segment_no="6" tag_type="text"><a href="">[18</a>]. CD 10 expression along with other B cell markers</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="76" segment_no="6" tag_type="text">(such as CD19/CD 20), was useful in diagnosis of FL.</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="77" segment_no="6" tag_type="text">These cases were negative for CD5. However in two cases</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="78" segment_no="6" tag_type="text">CD10 positivity was not demonstrated and a confident</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="79" segment_no="6" tag_type="text">diagnosis of FL was not possible. The FL is associated with</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="80" segment_no="6" tag_type="text">the charateristics t(14:18)(q32;21) translocation. This can</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="81" segment_no="6" tag_type="text">be demonstrated on cytology smears with the help of flu-</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="82" segment_no="6" tag_type="text">orescent in situ hybridisation (FISH)<a href=""> [19</a>]. This reciprocal</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="83" segment_no="6" tag_type="text">translocation may lead to oberexpression of BCL2 protein</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="84" segment_no="6" tag_type="text"><a href="">[20</a>]. Demonstration of BCL2 protein overexpression may</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="85" segment_no="6" tag_type="text">be helpful in histology sections where architecture is pre-</text>
<text top="439" left="313" width="29" height="9" font="font4" id="p1_t62" reading_order_no="86" segment_no="6" tag_type="text">served.</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="87" segment_no="7" tag_type="text">FCI alone was not very helpful in distinguishing DLBL,</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="88" segment_no="7" tag_type="text">lymphoblastic lymphoma and Burkitt's lymphoma, and</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="89" segment_no="7" tag_type="text">in those cases cytomorphology on the FNAC smears was</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="90" segment_no="7" tag_type="text">important. Lymphoblastic lymphomas are positive for</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="91" segment_no="7" tag_type="text">early markers such as TdT and CD34. B cells may also</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="92" segment_no="7" tag_type="text">express pan B-cell makers such as CD20 and lack surface</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="93" segment_no="7" tag_type="text">and sometimes cytoplasmic immunoglobulin. We did not</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="94" segment_no="7" tag_type="text">have adequate standardization of TdT and so we relied on</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="95" segment_no="7" tag_type="text">cytomrphology to diagnose lymphoblastic lymphomas.</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="96" segment_no="7" tag_type="text">The T-lymphoblastic lymphomas showed variable posi-</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="97" segment_no="7" tag_type="text">tivity of CD3, CD2 and CD10 markers. Wheras B-lym-</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="98" segment_no="7" tag_type="text">phoblastic lymphomas showed varaiable expression of</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="99" segment_no="7" tag_type="text">CD19, CD20 and CD10. Careful history and peripheral</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="100" segment_no="7" tag_type="text">blood picture should always take into consideration as</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="101" segment_no="7" tag_type="text">Acute myeloid leukaemia (AML-M0) may simulate simi-</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="102" segment_no="7" tag_type="text">lar picture. The Burkitt's lymphomas have characteristic</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t79" reading_order_no="103" segment_no="7" tag_type="text">cytomorphology. FNAC smears show dissociated cells</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="104" segment_no="7" tag_type="text">with deep blue vacuolated cytoplasm, having round regu-</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="105" segment_no="7" tag_type="text">lar nuclei with prominent nucleoli and abundant tingible</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="106" segment_no="7" tag_type="text">body macrophages in the background. High cell prolifer-</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="107" segment_no="7" tag_type="text">ation markers (Ki 67 index more than 99%) and t</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="108" segment_no="7" tag_type="text">(8;14)(q24;q32) translocation are the characteristic fea-</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="109" segment_no="7" tag_type="text">tures of Burkitt's lymphoma<a href="">s [13</a>]. The Burkitt lympho-</text>
<text top="87" left="55" width="283" height="7" font="font5" id="p1_t86" reading_order_no="5" segment_no="2" tag_type="title"><b>Table 4: Combined FNAC and FCI versus available histopathology diagnosis</b></text>
<text top="105" left="59" width="137" height="7" font="font5" id="p1_t87" reading_order_no="6" segment_no="3" tag_type="table"><b>Combined FNAC and FCI diagnosis</b></text>
<text top="105" left="361" width="74" height="7" font="font5" id="p1_t88" reading_order_no="7" segment_no="3" tag_type="table"><b>Histology diagnosis</b></text>
<text top="127" left="246" width="22" height="7" font="font5" id="p1_t89" reading_order_no="8" segment_no="3" tag_type="table"><b>DLBL</b></text>
<text top="127" left="285" width="10" height="7" font="font5" id="p1_t90" reading_order_no="9" segment_no="3" tag_type="table"><b>FL</b></text>
<text top="127" left="310" width="15" height="7" font="font5" id="p1_t91" reading_order_no="10" segment_no="3" tag_type="table"><b>SLL</b></text>
<text top="127" left="340" width="19" height="7" font="font5" id="p1_t92" reading_order_no="11" segment_no="3" tag_type="table"><b>MCL</b></text>
<text top="127" left="375" width="59" height="7" font="font5" id="p1_t93" reading_order_no="12" segment_no="3" tag_type="table"><b>Lymphob lastic</b></text>
<text top="127" left="460" width="24" height="7" font="font5" id="p1_t94" reading_order_no="13" segment_no="3" tag_type="table"><b>Other</b></text>
<text top="149" left="59" width="35" height="7" font="font6" id="p1_t95" reading_order_no="14" segment_no="3" tag_type="table">DLBL (15)</text>
<text top="149" left="246" width="8" height="7" font="font6" id="p1_t96" reading_order_no="15" segment_no="3" tag_type="table">14</text>
<text top="149" left="460" width="40" height="7" font="font6" id="p1_t97" reading_order_no="16" segment_no="3" tag_type="table">1 (Burkitt's)</text>
<text top="160" left="59" width="20" height="7" font="font6" id="p1_t98" reading_order_no="17" segment_no="3" tag_type="table">FL (4)</text>
<text top="160" left="285" width="4" height="7" font="font6" id="p1_t99" reading_order_no="18" segment_no="3" tag_type="table">4</text>
<text top="170" left="59" width="24" height="7" font="font6" id="p1_t100" reading_order_no="19" segment_no="3" tag_type="table">SLL (3)</text>
<text top="170" left="310" width="4" height="7" font="font6" id="p1_t101" reading_order_no="20" segment_no="3" tag_type="table">3</text>
<text top="180" left="59" width="28" height="7" font="font6" id="p1_t102" reading_order_no="21" segment_no="3" tag_type="table">MCL (2)</text>
<text top="180" left="340" width="4" height="7" font="font6" id="p1_t103" reading_order_no="22" segment_no="3" tag_type="table">2</text>
<text top="190" left="59" width="59" height="7" font="font6" id="p1_t104" reading_order_no="23" segment_no="3" tag_type="table">Lymphoblastic (3)</text>
<text top="190" left="375" width="4" height="7" font="font6" id="p1_t105" reading_order_no="24" segment_no="3" tag_type="table">3</text>
<text top="201" left="59" width="74" height="7" font="font6" id="p1_t106" reading_order_no="25" segment_no="3" tag_type="table">Suggestive of NHL (4)</text>
<text top="201" left="246" width="4" height="7" font="font6" id="p1_t107" reading_order_no="26" segment_no="3" tag_type="table">1</text>
<text top="201" left="310" width="4" height="7" font="font6" id="p1_t108" reading_order_no="27" segment_no="3" tag_type="table">1</text>
<text top="201" left="460" width="26" height="7" font="font6" id="p1_t109" reading_order_no="28" segment_no="3" tag_type="table">1 ALCL</text>
<text top="210" left="460" width="68" height="7" font="font6" id="p1_t110" reading_order_no="29" segment_no="3" tag_type="table">1 FL to large B-NHL</text>
<text top="232" left="59" width="492" height="7" font="font6" id="p1_t111" reading_order_no="30" segment_no="4" tag_type="text">DLBL = Diffuse large B lymphoma, SLL = Small lymphocytic lymphoma, FL = Follicular lymphoma, MCL = Mantle cell lymphoma, ALCL = Anaplastic </text>
<text top="241" left="59" width="433" height="7" font="font6" id="p1_t112" reading_order_no="31" segment_no="4" tag_type="text">large cell lymphoma, FNAC = Fine needle aspiration cytology, NHL = Non Hodgkin's lymphoma, FCI = Flow immunophenotyping</text>
</page>
</pdf2xml>
